Last Updated: November 7, 2026

Pharmazone Company Profile

« Back to Dashboard

What is the competitive landscape for PHARMAZONE

PHARMAZONE has one hundred and fifty-seven approved drugs.

Summary for Pharmazone

US Patents:	0
Tradenames:	126
Ingredients:	119
NDAs:	157

Drugs and US Patents for Pharmazone

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmazone	GABAPENTIN	gabapentin	CAPSULE;ORAL	219319-001	Aug 7, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Pharmazone	METFORMIN HYDROCHLORIDE	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	090295-001	Apr 29, 2016	AB1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Pharmazone	PREGABALIN	pregabalin	CAPSULE;ORAL	216197-006	Jul 18, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Pharmazone	TRANDOLAPRIL	trandolapril	TABLET;ORAL	078493-001	Aug 25, 2008		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for PHARMAZONE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.